Pascal Biosciences Inc banner

Pascal Biosciences Inc
XTSX:PAS

Watchlist Manager
Pascal Biosciences Inc Logo
Pascal Biosciences Inc
XTSX:PAS
Watchlist
Price: 0.015 CAD -25%
Market Cap: CA$983.9k

Intrinsic Value

PAS doesn't have a meaningful market cap.

The intrinsic value for Pascal Biosciences Inc (PAS) under the Base Case is 0.087 CAD. Compared with the current market price of 0.015 CAD, the stock appears Undervalued by 83% .

Intrinsic value calculated using DCF
CA$0.087

Do our valuations actually work? See backtest results .

PAS Intrinsic Value
CA$0.087
Undervaluation 83%
Intrinsic Value
Price CA$0.015
Monitor PAS
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value CA$0.07
Get notified when the price drops into your buy zone
Intrinsic Value CA$0.09
Margin of Safety 20% CA$0.07
Current Price CA$0.02
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about PAS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PAS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pascal Biosciences Inc.

Explain Valuation
Alternatives to PAS

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Pascal Biosciences Inc

Efficiency

Earnings Waterfall
Pascal Biosciences Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one PAS stock?

The intrinsic value for Pascal Biosciences Inc (PAS) under the Base Case is 0.087 CAD.

Is PAS stock undervalued or overvalued?

Compared with the current market price of 0.015 CAD, the stock appears Undervalued by 83% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett